Filing Details
- Accession Number:
- 0001883850-24-000022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-15 18:10:22
- Reporting Period:
- 2024-05-13
- Accepted Time:
- 2024-05-15 18:10:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1218629 | S Leonard Schleifer | 777 Old Saw Mill River Road Tarrytown NY 10591 | Bd. Co-Chair, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-13 | 203,204 | $399.66 | 577,633 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-13 | 144,433 | $976.79 | 433,200 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-05-14 | 22,698 | $979.16 | 410,502 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-14 | 2,302 | $980.10 | 408,200 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-15 | 7,864 | $979.05 | 400,336 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-15 | 295 | $980.64 | 400,041 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-15 | 1,081 | $981.50 | 398,960 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-15 | 235 | $982.66 | 398,725 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-15 | 250 | $983.91 | 398,475 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-15 | 305 | $984.00 | 398,170 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-15 | 281 | $985.72 | 397,889 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-15 | 103 | $986.57 | 397,786 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-15 | 228 | $987.46 | 397,558 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-15 | 299 | $988.76 | 397,259 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-05-13 | 203,204 | $0.00 | 203,204 | $399.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 250,000 | Indirect | 2023 GRAT |
| Common Stock | 5,932 | Indirect | By 401(k) Plan |
| Common Stock | 64,985 | Indirect | By Trust |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024.
- Represents volume-weighted average price of sales of 22,698 shares of Company stock on May 14, 2024 at prices ranging from $979.00 to $979.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 2,302 shares of Company stock on May 14, 2024 at prices ranging from $980.00 to $980.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 7,864 shares of Company stock on May 15, 2024 at prices ranging from $979.00 to $979.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 295 shares of Company stock on May 15, 2024 at prices ranging from $980.17 to $980.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 1,081 shares of Company stock on May 15, 2024 at prices ranging from $981.09 to $981.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 235 shares of Company stock on May 15, 2024 at prices ranging from $982.31 to $982.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 250 shares of Company stock on May 15, 2024 at prices ranging from $983.82 to $983.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 305 shares of Company stock on May 15, 2024 at prices ranging from $984.00 to $984.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 281 shares of Company stock on May 15, 2024 at prices ranging from $985.13 to $985.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 103 shares of Company stock on May 15, 2024 at prices ranging from $986.37 to $986.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 228 shares of Company stock on May 15, 2024 at prices ranging from $987.31 to $987.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- Represents volume-weighted average price of sales of 299 shares of Company stock on May 15, 2024 at prices ranging from $988.00 to $988.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
